Yield Theory

Stock research

Gen Digital Inc. GEN

Gen Digital sells consumer cybersecurity and identity-protection software under brands including Norton, Avast, and LifeLock.
Loading delayed market data…

Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.

Ticker
GEN
Exchange
NASDAQ
Sector
Tech
Founded

What moves GEN

Gen Digital Inc. sits in Information Technology. Semiconductors, software, and hardware — the companies building the digital and AI infrastructure the rest of the economy runs on. The forces that matter most for the sector — and therefore for GEN — are:

  • The AI capital-expenditure cycle
  • Interest rates and the cost of long-duration growth
  • Enterprise IT budgets and cloud migration
  • Export controls and the US–China chip race

Congressional trading in GEN

No matched GEN transaction appears in the current verified House Clerk snapshot. We do not turn a missing row into a claim that no member has ever traded the security.

Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.

The profile is free

GEN research stays free. Membership is the living thesis: what we believe, what we’re watching, and when conviction should end.

Get this month’s call for $15

How Yield Theory covers GEN

GEN intersects several of the themes in every Yield Theory issue. We don't chase headlines on individual tickers — we track where capital is rotating and explain what it means for the names in its path.

US markets

GEN — frequently asked questions

What sector is GEN in?

Gen Digital Inc. is classified in the Information Technology sector and trades on the NASDAQ.

Do members of Congress trade GEN?

The current verified House Clerk snapshot contains no matched GEN transaction rows. That is not proof that no lawmaker has ever traded the security.

Is GEN a good investment?

We don't publish one-line buy/sell ratings. Yield Theory members get the full macro thesis, catalysts, and risks behind every name we cover, so you can decide with conviction. This page is research, not investment advice.

This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.

See whether the GEN thesis still holds.

This page is company context and filings. Members get one sourced monthly call, a weekly evidence check, and the breakpoint written in advance. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included